SCHEMBL31708171

SCHEMBL31708171

CC(=O)Oc1cc(C)cc2[nH]cc(C(=O)C(=O)Cl)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC22A6 Q4U2R8 1/20 0.38
▸ KCNH2 Q12809 1/20 0.36
▸ KDM4E B2RXH2 5/20 0.36
▸ HSD17B10 Q99714 4/20 0.36
▸ NR4A2 P43354 2/20 0.36
▸ ELANE P08246 1/20 0.35
▸ LMNA P02545 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ GLA P06280 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ CFD P00746 1/20 0.31
▸ HPGD P15428 2/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25424327 0.86 NR4A2 (0.40) KCNH2NR4A2LMNARAB9AALDH1A1
SCHEMBL31708153 0.85 SLC22A6 (0.38) SLC22A6KDM4EHSD17B10LMNAALDH1A1
SCHEMBL31708141 0.84 NR4A2 (0.37) SLC22A6KCNH2KDM4EHSD17B10NR4A2
SCHEMBL20898149 0.80 SLC22A6 (0.49) SLC22A6KDM4EHSD17B10NR4A2LMNA
SCHEMBL29504147 0.80 SLC22A6 (0.49) SLC22A6KDM4EHSD17B10NR4A2LMNA
SCHEMBL25748342 0.77 SMN1; SMN2 (0.42) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL31708213 0.73 HSD17B10 (0.39) SLC22A6KDM4EHSD17B10NR4A2LMNA
SCHEMBL25246999 0.71 TUBB1 (0.37) LMNARAB9AMAPTMEN1KMT2A
SCHEMBL25438139 0.70 NR4A2 (0.39) KCNH2KDM4ENR4A2ALDH1A1MEN1
SCHEMBL17417628 0.70 NR4A2 (0.43) KDM4ENR4A2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback